Evidence map›Paper›PMID 41652471›Full record

ArticleActa neuropathologica communications2026

Large-scale mapping of the MCH network in ALS mice reveals the vulnerability of dopaminergic and GABAergic neurons in zona incerta.

Jelena Scekic-Zahirovic, Stefano Antonucci, Diana Wiesner, Chiara Ebner, Hussein El Hajj, Oumayma Aousji, Kareen Halablab, Yiting Fan, Anneka Zelaya, Gizem Yartas and 7 more

Abstract read
In one paragraph

Article in Acta neuropathologica communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jelena Scekic-ZahirovicGerman Center for Neurodegenerative Diseases-DZNE, Ulm, Germany. jelena.scekic-zahirovic@dzne.de.
Stefano AntonucciDepartment of Neurology, Ulm University, Ulm, Germany.
Diana WiesnerGerman Center for Neurodegenerative Diseases-DZNE, Ulm, Germany.
Chiara EbnerMolecular and Translational Neuroscience, Master program, Ulm University, Ulm, Germany.
Hussein El HajjDepartment of Neurology, Ulm University, Ulm, Germany.
Oumayma AousjiDepartment of Neurology, Ulm University, Ulm, Germany.
Kareen HalablabGerman Center for Neurodegenerative Diseases-DZNE, Ulm, Germany.
Yiting FanGenetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.
Anneka ZelayaGenetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.
Gizem YartasGerman Center for Neurodegenerative Diseases-DZNE, Ulm, Germany.
Karthik BaskarMolecular and Translational Neuroscience, Master program, Ulm University, Ulm, Germany.
E Anastasia ÇakmakMolecular and Translational Neuroscience, Master program, Ulm University, Ulm, Germany.
David BayerDepartment of Neurology, Ulm University, Ulm, Germany.
Hoon-Ki SungTranslational Medicine Program, The Hospital for Sick Children, Toronto, ON, Canada.
Luc DupuisUniversity of Strasbourg, INSERM, Strasbourg Translational neuroscience & Psychiatry STEP-CRBS, UMR-S 1329, 67000, Strasbourg, France.
Jeehye ParkGenetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.
Francesco RoselliGerman Center for Neurodegenerative Diseases-DZNE, Ulm, Germany. francesco.roselli@uni-ulm.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Weight loss and hypermetabolism are early and prognostically significant features of amyotrophic lateral sclerosis (ALS) and are associated with hypothalamic atrophy and degeneration of melanin-concentrating hormone (MCH) neurons that regulate energy balance. To investigate whether MCH vulnerability arises from upstream network dysfunction, we performed whole-brain retrograde rabies tracing in SOD1G93A mice. We identified an early, selective loss of monosynaptic inputs from the zona incerta (ZI), a dopaminergic (DA)/gamma-aminobutyric acid (GABA)ergic nucleus that preceded MCH neuron degeneration. Neurochemical profiling confirmed the DA/GABAergic identity of these ZI input neurons, and ZI/DAergic neurons later degenerated. ALS-related pathology emerged early in the ZI, paralleling pathology in the motor cortex, while anterograde mapping revealed that motor cortical projections preferentially targeted the ZI, linking vulnerable motor and metabolic networks. Loss of ZI/DAergic neurons was observed in conjunction with weight loss in non-SOD1 ALS models. These findings identify the ZI as an early-affected node within hypothalamic networks and suggest that disruption of DA/GABAergic inputs to MCH neurons is associated with subsequent MCH and DA neuronal vulnerability, degeneration and metabolic imbalance in ALS.

Indexed as

Amyotrophic Lateral SclerosisDopaminergic NeuronsGABAergic NeuronsHypothalamic HormonesMelaninsPituitary HormonesZona IncertaAnimalsDisease Models, AnimalHumansMaleMiceMice, TransgenicNeural PathwaysSuperoxide Dismutase-1Hypothalamic Hormonesmelanin-concentrating hormoneMelaninsPituitary HormonesSuperoxide Dismutase-1Amyotrophic lateral sclerosisDopaminergic neuronsMelanin-concentrating hormone neuronsMonosynaptic rabies tracingWeight lossZona incerta

Identifiers

PMID41652471
PMCPMC12930930

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.